Results 81 to 90 of about 2,359,697 (192)

Apoptosis and Signaling in Bullous Diseases: Pemphigus

open access: yes, 2015
Autoimmune bullous diseases comprise a heterogeneous group of disorders, which not only differ with regard to their immunological characteristics but also with regard to genetic and environmental predisposing factors.
David S. Rubenstein   +3 more
core   +1 more source

Hemorrhagic Bullous Angina: A Case Report and Review of the Literature [PDF]

open access: yes, 2016
Hemorrhagic bullous angina (HBA) is described as the sudden onset of one or more bullous lesions in the oral cavity, not attributable to other vesiculobullous diseases, blood dyscrasias, or autoimmune and vascular diseases.
Rafael Monsanto   +4 more
core   +1 more source

Evaluation of prolactin levels in patients with newly diagnosed pemphigus vulgaris and its correlation with pemphigus disease area index

open access: yesInternational Journal of Women's Dermatology, 2016
Background: Prolactin is a hormone; in addition to it known roles, it has immunomodulatory effects on lymphocytes maturation and immunoglobulins production.
Vahideh Lajevardi, MD   +5 more
doaj   +1 more source

Evaluation of the possible association between acantholysis and anti‐desmogleins 1 and 3 values in pemphigus vulgaris and pemphigus foliaceus

open access: yesJournal of Cutaneous Immunology and Allergy, 2019
Objectives Acantholysis is the main pathologic finding in pemphigus, and its location has been historically used to distinguish the major subtypes of pemphigus vulgaris (PV) and pemphigus foliaceus (PF).
Maryam Mobarakabadi   +9 more
doaj   +1 more source

Bullous Diseases.

open access: yes, 2017
International audienceAutoimmune bullous diseases are a heterogeneous group of blistering diseases affecting the skin and/or mucous membrane. Systemic corticosteroids, which are often associated with immunosuppressants, are the main treatment option for ...
Joly, Pascal   +3 more
core   +1 more source

Glucocorticoids in autoimmune bullous diseases: are neutrophils the key cellular target? [PDF]

open access: yes, 2013
The newly observed nongenomic effects of glucocorticoids on signaling pathways operating in neutrophils in vitro will stimulate further investigations on pathogenic mechanisms and drug actions in bullous skin ...
Simon, Hans-Uwe   +8 more
core   +1 more source

Coagulation activation in autoimmune bullous diseases

open access: yesClinical and Experimental Immunology, 2009
SummaryThe main autoimmune blistering skin disorders are pemphigus vulgaris (PV) and bullous pemphigoid (BP). They differ in the inflammatory infiltrate, which is more intense in BP. Inflammation is known to activate coagulation in several disorders. Local and systemic activation of coagulation was evaluated in BP and PV.
A.V. Marzano   +5 more
openaire   +4 more sources

Multiple Autoimmune Syndrome with Vitiligo, Autoimmune Thrombocytopenia and Autoimmune Dermoepidermal Bullous Dermatosis

open access: yes, 2015
Multiple auto-immune syndrome is defined by the coexistence of at least three different autoimmune diseases. Immune genetic predisposition and abnormalities of humeral and cell-mediated immunity seems to be implicated in their genesis.In this observation,
M Meziane   +6 more
core   +1 more source

Evaluation of the Complete Blood Count (CBC) Parameters in Patients With Hidradenitis Suppurativa and Their Correlation With Disease Severity: A Cross‐Sectional Study

open access: yesHealth Science Reports
Background and Aim Hidradenitis suppurativa is a chronic inflammatory skin disease characterized by painful, recurrent lesions most commonly affecting the axillary, groin, and inframammary areas. This study aimed to evaluate CBC parameters in HS patients
Zeinab Aryanian   +7 more
doaj   +1 more source

Autoimmune bullous skin disease managed with ayurvedic treatment: A case report

open access: yes, 2017
Autoimmune bullous diseases are a group of rare, acquired disorders characterized by overlapping features, resistance to treatment, and potential fatality. They need quick and proper management to avoid fatal complications.
Prashant Bedarkar   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy